Maple Leaf Green World Inc. Announces Submission of Abridgement application to Health Canada Aug 8, 2017
VolitionRx Limited Schedules Second Quarter 2017 Earnings Conference Call and Business Update Aug 3, 2017
RedHill Biopharma Announces Unanimous Positive DSMB Recommendation for Continuation of the Phase III Study with RHB-104 for Crohn’s Disease Aug 1, 2017 Life Science
Resverlogix Receives Approval Pathway from the FDA as to the Inclusion of USA Patients in the Phase 3 BETonMACE Trial Jul 26, 2017 Life Science
Maple Leaf Green World Inc. Announces Submission of a Medical Marijuana Establishment Certificate Transfer Application to the City of Henderson, Nevada Jul 26, 2017 Life Science
Resverlogix Files 2017 Year-End Disclosure Documents and Announces Plans to Host a Symposium at the European Society of Cardiology Congress 2017 Jul 26, 2017 Life Science
Nanjing Frontier Acquires Rights to Rockefeller University HIV/AIDS Antibody Jul 25, 2017 Life Science
DelMar Pharmaceuticals Receives Approval from China’s Human Genetic Resources Administration to Initiate Phase 2 Clinical Trial in Newly Diagnosed GBM Jul 25, 2017 Life Science
VolitionRx Limited to host a conference call regarding a 13,500 Subject Colorectal Cancer Screening Trial with the Early Detection Research Network of the U.S. National Cancer Institute Jul 20, 2017 Life Science
